Document is current
Any future updates will be listed below
-
Authors
Anderson, Stephanie
Karlstaedt, Anja
Young, Megan
Karatzia, Loucia
Cullen, Fenn
Chen, Jianmin
O’Riordan, Caroline E.
Barnes, Michael R.
Štaka, Zorana https://orcid.org/0000-0002-3779-7581
Albee, Lauren J.
Garrod-Ketchley, Conor
Dambure, Sanushi
Prag, Hiran A. https://orcid.org/0000-0002-4753-8567
Cvetko, Filip
Miller, Jack J. J. J.
Thiemermann, Christoph
Lewis, Andrew J. M.
Murphy, Michael P. https://orcid.org/0000-0003-1115-9618
Smith, David M. https://orcid.org/0000-0001-6831-280X
Henson, Sian M.
Tyler, Damian J. https://orcid.org/0000-0002-0780-8905
Aksentijevic, Dunja https://orcid.org/0000-0002-8480-6727
- License Information
-
More Information
Article History
Received: 23 April 2024
Accepted: 15 December 2025
First Online: 23 February 2026
Competing interests
: D.A. has a research study and exclusive license option agreement with AstraZeneca UK to study impact of AZD1656 on T cell trafficking and cardiac metabolism. D.M.S. is an employee and shareholder of AstraZeneca. The other authors declare no competing interests.
